ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1,2-Bis(diphenylphosphino)ethane → Benzyl 4-(2-acetamido-1-(tert-butylamino)-1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)piperidine-1-carboxylate

HRID 579604
印刷

反応式

HRID 579604 の反応式
C1(P(C2C=CC=CC=2)CCP(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[CH3:29][C:30]1([CH3:37])[C:34]([CH3:36])([CH3:35])[O:33][BH:32][O:31]1.[C:38]([NH:41][C:42]([CH:54]1[CH2:59][CH2:58][N:57]([C:60]([O:62][CH2:63][C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][CH:65]=2)=[O:61])[CH2:56][CH2:55]1)([CH2:50][CH2:51][CH:52]=[CH2:53])[C:43]([NH:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])(=[O:40])[CH3:39]>C1COCC1.[Ir+].ClC1CCC=CCCC=1>[C:38]([NH:41][C:42]([CH:54]1[CH2:55][CH2:56][N:57]([C:60]([O:62][CH2:63][C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][CH:65]=2)=[O:61])[CH2:58][CH2:59]1)([CH2:50][CH2:51][CH2:52][CH2:53][B:32]1[O:33][C:34]([CH3:36])([CH3:35])[C:30]([CH3:37])([CH3:29])[O:31]1)[C:43]([NH:45][C:46]([CH3:49])([CH3:47])[CH3:48])=[O:44])(=[O:40])[CH3:39]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 742671,2-Bis(diphenylphosphino)ethaneHCID 27347684,4,5,5-Tetramethyl[1,3,2]dioxaborolaneHCID 66833672Benzyl 4-(2-acetamido-1-(tert-butylamino)-1-oxohex-5-en-2-yl)piperidine-1-carboxylate

生成物 1

HCID 66832700Benzyl 4-(2-acetamido-1-(tert-butylamino)-1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)piperidine-1-carboxylate収率 71%

試薬・触媒・溶媒 2

HCID 178478077HCID 178478077、化合物触媒
HCID 8028Tetrahydrofuran溶媒

実験手順

While under an argon atmosphere, a solution of 1,2-bis(diphenylphosphino)ethane (306 mg, 0.77 mmol) and chloro-1,5-cyclooctadiene iridium (I) dimer (258 mg, 0.39 mmol) in anhydrous THF (30 mL) was treated with 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.48 g, 1.67 mL, 11.6 mmol) in one portion. After stirring for 15 minutes the solution was cooled to 5° C. (ice-water batch) and treated with benzyl 4-(2-acetamido-1-(tert-butylamino)-1-oxohex-5-en-2-yl)piperidine-1-carboxylate (3.42 g, 7.70 mmol) in one portion. After the addition was complete, the cooling bath was removed and the reaction mixture was allowed to warm up to room temperature. After 2 hours of stirring the reaction was quenched with saturated aqueous sodium bicarbonate (50 mL) and extracted using ethyl acetate (2×150 mL). The organic layer was dried over MgSO4, filtered and concentrated. MPLC purification (100 g column, 40-80% ethyl acetate in heptane) gave benzyl 4-(2-acetamido-1-(tert-butylamino)-1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)piperidine-1-carboxylate as a colorless oil (3.10 g, 71% yield). 1H NMR (CDCl3, 300 MHz) δ 7.36-7.30 (m, 5H), 6.94 (bs, 1H), 5.46 (s, 1H), 5.10 (s, 2H), 4.36-4.10 (m, 2H), 2.86-2.60 (m, 3H), 2.40-2.28 (bt, J=12.3 Hz, 1H), 1.98 (s, 3H), 1.78-1.61 (m, 2H), 1.49-1.17 (m, 5H), 1.33 (s, 9H), 1.20 (s, 8H), 1.12-0.94 (m, 2H), 0.73 (t, J=7.8 Hz, 2H).

後処理

  1. additionAfter the addition
  2. customthe cooling bath was removed
  3. stirringAfter 2 hours of stirring the reaction
  4. customwas quenched with saturated aqueous sodium bicarbonate (50 mL)
  5. extractionextracted
  6. dry with materialThe organic layer was dried over MgSO4
  7. filtrationfiltered
  8. concentrationconcentrated
  9. customMPLC purification (100 g column, 40-80% ethyl acetate in heptane)

出典と根拠

ORDレコード
ord-30d5ad27943341a095dbcf5cd7ee9440
出典データセット
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09040703B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート